Magnesium L-threonate trials recruiting now

2 registrations that name magnesium L-threonate as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Trial Finder Read from ClinicalTrials.gov Oct 20, 2026 The Magnesium L-threonate supplement page

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 2 registrations

Status

Phase

Location

2US sites across 2 states

All 2 registrations

RecruitingNCT07640685

UCLA Magnesium Formulation Athlete Study

No phase
University of California, Los Angeles
About 150 people
Started Oct 5, 2026

In plain words A study of magnesium L-threonate in people 18 to 35, run by University of California, Los Angeles. It plans to enroll about 150 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 35; healthy volunteers accepted. Conditions: Athletic Performance; Recovery; Sleep.

Age 18-35 years.
Current NCAA Division I athlete at UCLA.
Actively participating in team training and/or competition.
Willing to wear a WHOOP 4.0 device continuously during the baseline and treatment periods of the study block.

4 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Magnesium glycinate; Magnesium L-threonate; Placebo

Registered summary

This randomized, double-blind, placebo-controlled trial will compare magnesium glycinate, magnesium L-threonate, and placebo in UCLA varsity athletes. Participants will complete a baseline monitoring period followed by 4 weeks of blinded nightly supplementation. WHOOP 4.0 data will be used to evaluate sleep efficiency, total sleep time, sleep consistency, heart rate variability, resting heart rate, and recovery metrics. Baseline and final testing will assess selected reaction and physical performance outcomes. The full summary is on the listing.

Where, as registered

1 US site in 1 state.

RecruitingNCT06902285

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Phase 4
University of Miami
About 64 people
Started Apr 21, 2025

In plain words A Phase 4 study of magnesium L-threonate in people 18 and older, run by University of Miami. It plans to enroll about 64 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older. Conditions: Sleep; Knee Osteoarthritis.

Patients undergoing primary total knee or hip arthroplasty at the University of Miami Hospital
Patients > 18 years of age
Subjects must be capable of providing informed consent
English or Spanish-speaking

The exclusion criteria are on the listing.

What it tests, as registered

Magnesium Threonate; Control

Registered summary

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery

Where, as registered

1 US site in 1 state.

ClinicalTrials.gov lists 3 open registrations for this search, including ones where magnesium L-threonate is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Also on Kymata

Supplement brands we have checkedEvery supplement brand we have reviewed.